Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial

Overview of attention for article published in Gut, November 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

So far, Altmetric has seen 18 X posts from 18 X users, with an upper bound of 57,413 followers.

Budesonide should NOT be an issue in terms of systemic steroid risk, particularly at low doses if it is tolerated!

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 14 additional X posts.